{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:08:01Z","timestamp":1787879281766,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"BUPT Excellent Ph.D. Students Foundation","award":["No. CX2023117"],"award-info":[{"award-number":["No. CX2023117"]}]},{"name":"Beijing Municipal Natural Science Foundation","award":["No. 7244519"],"award-info":[{"award-number":["No. 7244519"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. T2425027, No.62333002"],"award-info":[{"award-number":["No. T2425027, No.62333002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04674-6","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T02:56:44Z","timestamp":1770260204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A neuroimaging biomarker for disease staging in clinically diagnosed Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhuangzhuang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaozhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengluan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"issue":"1","key":"4674_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12916-025-04295-5","volume":"23","author":"JC Palmer","year":"2025","unstructured":"Palmer JC, Hart E, Anderson E, Love S, Lawlor DA. Exploring the effect of pre-clinical Alzheimer\u2019s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank. BMC Med. 2025;23(1):483.","journal-title":"BMC Med"},{"issue":"1","key":"4674_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt155","volume":"5","author":"B Lam","year":"2013","unstructured":"Lam B, Masellis M, Freedman M, Stuss DT, Black SE. Clinical, imaging, and pathological heterogeneity of the Alzheimer\u2019s disease syndrome. Alzheimers Res Ther. 2013;5(1):1.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"4674_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.biopsych.2020.01.016","volume":"88","author":"M Habes","year":"2020","unstructured":"Habes M, Grothe MJ, Tunc B, McMillan C, Wolk DA, Davatzikos C. Disentangling heterogeneity in Alzheimer\u2019s disease and related dementias using data-driven methods. Biol Psychiatry. 2020;88(1):70\u201382.","journal-title":"Biol Psychiatry"},{"issue":"6","key":"4674_CR4","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1093\/brain\/awad059","volume":"146","author":"JL Robinson","year":"2023","unstructured":"Robinson JL, Xie SX, Baer DR, Suh E, Van Deerlin VM, Loh NJ, et al. Pathological combinations in neurodegenerative disease are heterogeneous and disease-associated. Brain. 2023;146(6):2557\u201369.","journal-title":"Brain"},{"key":"4674_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148675","volume":"1823","author":"P Chen","year":"2024","unstructured":"Chen P, Zhang S, Zhao K, Kang X, Rittman T, Liu Y. Robustly uncovering the heterogeneity of neurodegenerative disease by using data-driven subtyping in neuroimaging: a review. Brain Res. 2024;1823:148675.","journal-title":"Brain Res"},{"key":"4674_CR6","unstructured":"Gauthier S R-NP, Morais JA, Webster C. World Alzheimer Report 2021: journey through the diagnosis of dementia. 2021."},{"issue":"1","key":"4674_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12035","volume":"6","author":"D Tjandra","year":"2020","unstructured":"Tjandra D, Migrino RQ, Giordani B, Wiens J. Cohort discovery and risk stratification for Alzheimer\u2019s disease: an electronic health record-based approach. Alzheimers Dement (N Y). 2020;6(1):e12035.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"12","key":"4674_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41575-020-00368-3","volume":"17","author":"MA Hull","year":"2020","unstructured":"Hull MA, Rees CJ, Sharp L, Koo S. A risk-stratified approach to colorectal cancer prevention and diagnosis. Nat Rev Gastroenterol Hepatol. 2020;17(12):773\u201380.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4674_CR9","doi-asserted-by":"crossref","unstructured":"Prasher VP, Qureshi K, Fatema S. Role of anti-dementia medication. Mental health, intellectual and developmental disabilities and the ageing process. 2021:207\u201325.","DOI":"10.1007\/978-3-030-56934-1_13"},{"issue":"8","key":"4674_CR10","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack CR Jr, Andrews JS, Beach TG, Buracchio T, Dunn B, Graf A, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"4674_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","volume":"76","author":"N Mattsson","year":"2019","unstructured":"Mattsson N, Palmqvist S, Stomrud E, Vogel J, Hansson O. Staging beta-amyloid pathology with amyloid positron emission tomography. JAMA Neurol. 2019;76(11):1319\u201329.","journal-title":"JAMA Neurol"},{"issue":"2","key":"4674_CR12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2967\/jnumed.119.235879","volume":"61","author":"E Fantoni","year":"2020","unstructured":"Fantoni E, Collij L, Lopes Alves I, Buckley C, Farrar G, consortium A. The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging. J Nucl Med. 2020;61(2):166\u201371.","journal-title":"J Nucl Med"},{"key":"4674_CR13","doi-asserted-by":"crossref","unstructured":"Lowe VJ, Wiste HJ, Senjem ML, Weigand SD, Therneau TM, Boeve BF, et al. Widespread brain tau and its association with ageing, Braak stage and Alzheimer\u2019s dementia. Brain. 2018;141(1):271\u201387.","DOI":"10.1093\/brain\/awx320"},{"issue":"4","key":"4674_CR14","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1002\/alz.13654","volume":"20","author":"CS Fonseca","year":"2024","unstructured":"Fonseca CS, Baker SL, Dobyns L, Janabi M, Jagust WJ, Harrison TM. Tau accumulation and atrophy predict amyloid independent cognitive decline in aging. Alzheimers Dement. 2024;20(4):2526\u201337.","journal-title":"Alzheimers Dement"},{"key":"4674_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102276","volume":"65","author":"K Zhao","year":"2023","unstructured":"Zhao K, Chen P, Alexander-Bloch A, Wei Y, Dyrba M, Yang F, et al. A neuroimaging biomarker for Individual Brain-Related Abnormalities In Neurodegeneration (IBRAIN): a cross-sectional study. EClinicalMedicine. 2023;65:102276.","journal-title":"EClinicalMedicine"},{"issue":"41","key":"4674_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado8837","volume":"10","author":"K Zhao","year":"2024","unstructured":"Zhao K, Wang D, Wang D, Chen P, Wei Y, Tu L, et al. Macroscale connectome topographical structure reveals the biomechanisms of brain dysfunction in Alzheimer\u2019s disease. Sci Adv. 2024;10(41):eado8837.","journal-title":"Sci Adv"},{"issue":"3","key":"4674_CR17","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230173","volume":"308","author":"S Haller","year":"2023","unstructured":"Haller S, Jager HR, Vernooij MW, Barkhof F. Neuroimaging in dementia: more than typical Alzheimer disease. Radiology. 2023;308(3):e230173.","journal-title":"Radiology"},{"issue":"6","key":"4674_CR18","doi-asserted-by":"publisher","DOI":"10.1148\/ryai.240508","volume":"7","author":"X Kang","year":"2025","unstructured":"Kang X, Lin J, Zhao K, Yan S, Chen P, Wang D, et al. Structural MRI-based computer-aided diagnosis models for Alzheimer disease: insights into misclassifications and diagnostic limitations. Radiol Artif Intell. 2025;7(6):e240508.","journal-title":"Radiol Artif Intell"},{"key":"4674_CR19","doi-asserted-by":"crossref","unstructured":"\u00d6hman F, Hassenstab J, Berron D, Sch\u00f6ll M, Papp KV. Current advances in digital cognitive assessment for preclinical Alzheimer\u2019s disease. Alzheimer\u2019s Dement: Diagn Assess Dis Monit. 2021;13(1):e12217.","DOI":"10.1002\/dad2.12217"},{"issue":"10","key":"4674_CR20","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1093\/brain\/awab165","volume":"144","author":"S Verdi","year":"2021","unstructured":"Verdi S, Marquand AF, Schott JM, Cole JH. Beyond the average patient: how neuroimaging models can address heterogeneity in dementia. Brain. 2021;144(10):2946\u201353.","journal-title":"Brain"},{"issue":"7","key":"4674_CR21","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1093\/brain\/awae118","volume":"147","author":"H Baumeister","year":"2024","unstructured":"Baumeister H, Vogel JW, Insel PS, Kleineidam L, Wolfsgruber S, Stark M, et al. A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings. Brain. 2024;147(7):2400\u201313.","journal-title":"Brain"},{"issue":"14","key":"4674_CR22","doi-asserted-by":"publisher","first-page":"2000675","DOI":"10.1002\/advs.202000675","volume":"7","author":"D Jin","year":"2020","unstructured":"Jin D, Zhou B, Han Y, Ren J, Han T, Liu B, et al. Generalizable, reproducible, and neuroscientifically interpretable imaging biomarkers for Alzheimer\u2019s disease. Adv Sci (Weinh). 2020;7(14):2000675.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"4674_CR23","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1016\/j.clinph.2013.05.014","volume":"124","author":"P Wang","year":"2013","unstructured":"Wang P, Zhang X, Liu Y, Liu S, Zhou B, Zhang Z, et al. Perceptual and response interference in Alzheimer\u2019s disease and mild cognitive impairment. Clin Neurophysiol. 2013;124(12):2389\u201396.","journal-title":"Clin Neurophysiol"},{"issue":"2","key":"4674_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/j.neuroimage.2011.08.049","volume":"59","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Liu Y, Jiang T, Zhou B, An N, Dai H, et al. Altered spontaneous activity in Alzheimer\u2019s disease and mild cognitive impairment revealed by regional homogeneity. Neuroimage. 2012;59(2):1429\u201340.","journal-title":"Neuroimage"},{"issue":"7","key":"4674_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.2174\/15672050113109990146","volume":"10","author":"B Zhou","year":"2013","unstructured":"Zhou B, Liu Y, Zhang Z, An N, Yao H, Wang P, et al. Impaired functional connectivity of the thalamus in Alzheimer\u2019s disease and mild cognitive impairment: a resting-state fMRI study. Curr Alzheimer Res. 2013;10(7):754\u201366.","journal-title":"Curr Alzheimer Res"},{"key":"4674_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroimage.2016.03.067","volume":"144","author":"K Brueggen","year":"2017","unstructured":"Brueggen K, Grothe MJ, Dyrba M, Fellgiebel A, Fischer F, Filippi M, et al. The European DTI study on dementia\u2014a multicenter DTI and MRI study on Alzheimer\u2019s disease and mild cognitive impairment. Neuroimage. 2017;144:305\u20138.","journal-title":"Neuroimage"},{"key":"4674_CR27","unstructured":"EDSD. European DLB Consortium Dementia (EDSD) Registry: European Dementia with Lewy Bodies Consortium. 2014. Available from: https:\/\/edsd.infoa."},{"issue":"5","key":"4674_CR28","doi-asserted-by":"publisher","first-page":"e111","DOI":"10.1016\/j.jalz.2013.05.1769","volume":"9","author":"MW Weiner","year":"2013","unstructured":"Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, et al. The Alzheimer\u2019s disease neuroimaging initiative: a review of papers published since its inception. Alzheimers Dement. 2013;9(5):e111\u201394.","journal-title":"Alzheimers Dement"},{"key":"4674_CR29","unstructured":"ADNI. Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database: Laboratory of Neuro Imaging (LONI), University of Southern California. 2003. Available from: https:\/\/adni.loni.usc.edu."},{"issue":"3","key":"4674_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/WAD.0b013e318142774e","volume":"21","author":"DL Beekly","year":"2007","unstructured":"Beekly DL, Ramos EM, Lee WW, Deitrich WD, Jacka ME, Wu J, et al. The National Alzheimer\u2019s Coordinating Center (NACC) database: the uniform data set. Alzheimer Dis Assoc Disord. 2007;21(3):249\u201358.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"4674_CR31","unstructured":"NACC. National Alzheimer's Coordinating Center (NACC) Uniform DataSet: National Alzheimer's Coordinating Center, University of Washington. 2005. Available from: National Alzheimer's Coordinating Center, University of Washington."},{"issue":"4","key":"4674_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"4674_CR33","doi-asserted-by":"publisher","first-page":"5056","DOI":"10.1109\/JBHI.2025.3543218","volume":"29","author":"Z Li","year":"2025","unstructured":"Li Z, Zhao K, Chen P, Wang D, Yao H, Zhou B, et al. Disentangled representation learning for capturing individualized brain atrophy via pseudo-healthy synthesis. IEEE J Biomed Health Inform. 2025;29(7):5056\u201368.","journal-title":"IEEE J Biomed Health Inform"},{"issue":"8","key":"4674_CR34","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.1093\/cercor\/bhw157","volume":"26","author":"L Fan","year":"2016","unstructured":"Fan L, Li H, Zhuo J, Zhang Y, Wang J, Chen L, et al. The Human Brainnetome Atlas: a new brain atlas based on connectional architecture. Cereb Cortex. 2016;26(8):3508\u201326.","journal-title":"Cereb Cortex"},{"issue":"10","key":"4674_CR35","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.1002\/alz.14160","volume":"20","author":"DJ Harvey","year":"2024","unstructured":"Harvey DJ, Tosun D, Jack CR Jr., Weiner M, Beckett LA, Alzheimer\u2019s disease neuroimaging I. Standardized statistical framework for comparison of biomarkers: techniques from ADNI. Alzheimers Dement. 2024;20(10):6834\u201343.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"4674_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1093\/cercor\/bhn113","volume":"19","author":"BC Dickerson","year":"2009","unstructured":"Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, et al. The cortical signature of Alzheimer\u2019s disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009;19(3):497\u2013510.","journal-title":"Cereb Cortex"},{"issue":"3","key":"4674_CR37","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jalz.2016.08.005","volume":"13","author":"CR Jack Jr","year":"2017","unstructured":"Jack CR Jr, Wiste HJ, Weigand SD, Therneau TM, Lowe VJ, Knopman DS, et al. Defining imaging biomarker cut points for brain aging and Alzheimer\u2019s disease. Alzheimers Dement. 2017;13(3):205\u201316.","journal-title":"Alzheimers Dement"},{"issue":"9","key":"4674_CR38","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s12264-024-01218-x","volume":"40","author":"X Kang","year":"2024","unstructured":"Kang X, Wang D, Lin J, Yao H, Zhao K, Song C, et al. Convergent neuroimaging and molecular signatures in mild cognitive impairment and Alzheimer\u2019s disease: a data-driven meta-analysis with N = 3,118. Neurosci Bull. 2024;40(9):1274\u201386.","journal-title":"Neurosci Bull"},{"issue":"9","key":"4674_CR39","doi-asserted-by":"publisher","first-page":"232596712311937","DOI":"10.1177\/23259671231193768","volume":"11","author":"P Ganokroj","year":"2023","unstructured":"Ganokroj P, Hollenbeck J, Peebles AM, Brown JR, Hanson JA, Whalen RJ, et al. Humeral head reconstruction with osteochondral allograft: bone plug optimization for Hill-Sachs lesions using CT-based computer modeling analysis. Orthop J Sports Med. 2023;11(9):23259671231193770.","journal-title":"Orthop J Sports Med"},{"issue":"9","key":"4674_CR40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.biopsych.2022.06.019","volume":"93","author":"P Chen","year":"2023","unstructured":"Chen P, Yao H, Tijms BM, Wang P, Wang D, Song C, et al. Four distinct subtypes of Alzheimer\u2019s disease based on resting-state connectivity biomarkers. Biol Psychiatry. 2023;93(9):759\u201369.","journal-title":"Biol Psychiatry"},{"key":"4674_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","volume":"14","author":"M Su\u00e1rez-Calvet","year":"2019","unstructured":"Su\u00e1rez-Calvet M, Morenas-Rodr\u00edguez E, Kleinberger G, Schlepckow K, Araque Caballero M\u00c1, Franzmeier N, et al. Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology. Mol Neurodegener. 2019;14:1\u201314.","journal-title":"Mol Neurodegener"},{"issue":"17","key":"4674_CR42","doi-asserted-by":"publisher","first-page":"e1692","DOI":"10.1212\/WNL.0000000000200148","volume":"98","author":"LE Collij","year":"2022","unstructured":"Collij LE, Salvado G, Wottschel V, Mastenbroek SE, Schoenmakers P, Heeman F, et al. Spatial-temporal patterns of beta-amyloid accumulation: a subtype and stage inference model analysis. Neurology. 2022;98(17):e1692\u2013703.","journal-title":"Neurology"},{"issue":"10248","key":"4674_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"issue":"12","key":"4674_CR44","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","volume":"58","author":"DR Thal","year":"2002","unstructured":"Thal DR, Rub U, Orantes M, Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology. 2002;58(12):1791\u2013800.","journal-title":"Neurology"},{"issue":"11","key":"4674_CR45","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Pichet Binette A, Groot C, Smith R, Strandberg O, Palmqvist S, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28(11):2381\u20137.","journal-title":"Nat Med"},{"issue":"9","key":"4674_CR46","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.molmed.2022.05.008","volume":"28","author":"J Therriault","year":"2022","unstructured":"Therriault J, Zimmer ER, Benedet AL, Pascoal TA, Gauthier S, Rosa-Neto P. Staging of Alzheimer\u2019s disease: past, present, and future perspectives. Trends Mol Med. 2022;28(9):726\u201341.","journal-title":"Trends Mol Med"},{"issue":"12","key":"4674_CR47","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1212\/WNL.0000000000001401","volume":"84","author":"L Wang","year":"2015","unstructured":"Wang L, Benzinger TL, Hassenstab J, Blazey T, Owen C, Liu J, et al. Spatially distinct atrophy is linked to beta-amyloid and tau in preclinical Alzheimer disease. Neurology. 2015;84(12):1254\u201360.","journal-title":"Neurology"},{"issue":"4","key":"4674_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41582-024-00942-2","volume":"20","author":"J Therriault","year":"2024","unstructured":"Therriault J, Schindler SE, Salvado G, Pascoal TA, Benedet AL, Ashton NJ, et al. Biomarker-based staging of Alzheimer disease: rationale and clinical applications. Nat Rev Neurol. 2024;20(4):232\u201344.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"4674_CR49","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.222471","volume":"308","author":"B Wang","year":"2023","unstructured":"Wang B, Pan Y, Xu S, Zhang Y, Ming Y, Chen L, et al. Quantitative cerebral blood volume image synthesis from standard MRI using image-to-image translation for brain tumors. Radiology. 2023;308(2):e222471.","journal-title":"Radiology"},{"issue":"10","key":"4674_CR50","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41380-019-0441-1","volume":"24","author":"AF Marquand","year":"2019","unstructured":"Marquand AF, Kia SM, Zabihi M, Wolfers T, Buitelaar JK, Beckmann CF. Conceptualizing mental disorders as deviations from normative functioning. Mol Psychiatry. 2019;24(10):1415\u201324.","journal-title":"Mol Psychiatry"},{"key":"4674_CR51","doi-asserted-by":"crossref","unstructured":"Rahman Siddiquee MM, Shah J, Wu T, Chong C, Schwedt T, Li B, editors. HealthyGAN: learning from unannotated medical images to detect anomalies associated with human disease. International Workshop on Simulation and Synthesis in Medical Imaging. Berlin, Heidelberg: Springer; 2022.","DOI":"10.1007\/978-3-031-16980-9_5"},{"issue":"6597","key":"4674_CR52","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.abm2461","volume":"376","author":"A Aglinskas","year":"2022","unstructured":"Aglinskas A, Hartshorne JK, Anzellotti S. Contrastive machine learning reveals the structure of neuroanatomical variation within autism. Science. 2022;376(6597):1070\u20134.","journal-title":"Science"},{"issue":"1","key":"4674_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-06648-x","volume":"7","author":"L Zheng","year":"2024","unstructured":"Zheng L, Zhou C, Mao C, Xie C, You J, Cheng W, et al. Contrastive machine learning reveals Parkinson\u2019s disease specific features associated with disease severity and progression. Commun Biol. 2024;7(1):954.","journal-title":"Commun Biol"},{"issue":"11","key":"4674_CR54","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1001\/archneur.1995.00540350081020","volume":"52","author":"JJ Locascio","year":"1995","unstructured":"Locascio JJ, Growdon JH, Corkin S. Cognitive test performance in detecting, staging, and tracking Alzheimer\u2019s disease. Arch Neurol. 1995;52(11):1087\u201399.","journal-title":"Arch Neurol"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04674-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04674-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04674-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T14:03:53Z","timestamp":1773065033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04674-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4674"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04674-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocols were approved by the relevant Medical Ethics Committees. The MCAD cohort and the Xuanwu Hospital cohort were registered on ClinicalTrials.gov under the identifiers NCT02353884 and NCT02225964, respectively. All participants provided written informed consent prior to participation. The ADNI was approved by the Institutional Review Boards of all participating centers, and written informed consent was obtained from all participants or authorized representatives according to the 1975 Declaration of Helsinki. Data included from the NACC were collected at multiple Alzheimer\u2019s Disease Research Centers, each of which received approval from its local Institutional Review Board and conducted the study in accordance with internationally accepted ethical standards. The EDSD was approved by the local ethics committees at each participating centre and was conducted in accordance with internationally accepted ethical standards for human research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}